Quantcast

Latest Paladin Labs Inc. Stories

2014-09-30 08:32:22

Trelstar® one-, three-, and six-month dosing options now available TORONTO and LAUSANNE, Switzerland, September 30, 2014 /PRNewswire/ -- Trelstar(R) (triptorelin pamoate), indicated in Canada for the palliative treatment of hormone dependent advanced prostate cancer,[1] is now available in a six-month dosing option (22.5 mg). The new dosing option eases the burden on patients, with a decreased number of injections and a low incidence of injection site pain, while providing...

2014-05-14 16:29:21

(all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON, May 14, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC), a clinical stage biotechnology company, today announced financial results for the third quarter of Fiscal 2014 (ended March 31, 2014). Highlights of the year-to-date include: -- Successful execution of Animal Health division sale to Vétoquinol for $61 million plus working capital adjustment; --...

2014-04-10 08:29:34

GREENWOOD VILLAGE, Colo., April 10, 2014 /PRNewswire/ -- Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE) today announced that its wholly-owned subsidiary Vyrix Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing late-stage prescription pharmaceuticals to improve men's sexual health, has signed an agreement with Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, to provide exclusive rights to market, sell and distribute...

2014-02-28 12:27:50

DUBLIN, Feb. 28, 2014 /PRNewswire/ -- -- Accretive transaction accelerates Endo's transformation into a leading specialty healthcare company -- Creates a compelling financial and operational platform for future growth -- Establishes Endo's global pharmaceuticals footprint -- Endo Health Solutions Inc. becomes Endo International plc Endo International plc (Nasdaq: ENDP; TSX: ENL), formerly Endo Health Solutions Inc., announced today that it has completed...

2014-02-26 12:26:21

MALVERN, Pa., Feb. 26, 2014 /PRNewswire/ -- Endo Health Solutions Inc. (NASDAQ: ENDP) ("Endo") today announced that, at the shareholder meeting held today, proposals related to Endo's proposed acquisition of Paladin Labs Inc. (TSX: PLB) ("Paladin") were approved by Endo's shareholders. As previously announced, on November 5, 2013, Endo and Paladin entered into an arrangement agreement pursuant to which each of Endo and Paladin will be acquired by a new Irish holding company, Endo...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related